Takeda Pharmaceutical Company Limited Asset Turnover Ratio (TAK), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Takeda Pharmaceutical Company Limited  (NYSE: TAK)
 

Takeda Pharmaceutical Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Takeda Pharmaceutical Company Limited asset turnover ratio, the ability of Takeda Pharmaceutical Company Limited's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.32 in the fourth quarter (Mar 31 2025), a new company high.

Within sector 116 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 181 to 2550.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TAK Asset Turnover Ratio (Mar 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2024)
IV. Quarter
Y / Y Asset Change -12.18 % -12.18 % -12.18 % -12.18 % 6.88 %
Y / Y Revenue Change 0.06 % - - - 4.53 %
Asset Turnover Ratio (TTM) 0.32 - - - 0.28
TAK's Total Ranking # 2550 # 181 # # #
Seq. Asset Change 0 % 0 % 0 % -12.18 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 117
Healthcare Sector # 378
Overall Market # 2550

Asset Turnover Ratio Statistics
High Average Low
0.32 0.3 0.28
(Mar 31 2025)   (Mar 31 2024)




TAK Company Profile • Back to TAK Efficiency Comparisons • Compare TAK Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2025 Assets at quarter ending Mar 31 2025
Bionexus Gene Lab Corp   0.88 $ 9.266  Millions$ 10.512  Millions
Cadre Holdings inc   0.88 $ 558.440  Millions$ 636.563  Millions
National Vision Holdings Inc   0.88 $ 1,791.121  Millions$ 2,046.138  Millions
Ptc Therapeutics inc   0.87 $ 1,772.758  Millions$ 2,029.751  Millions
Embecta Corp   0.87 $ 1,078.100  Millions$ 1,239.575  Millions
Lensar Inc   0.87 $ 57.065  Millions$ 65.670  Millions
Ironwood Pharmaceuticals inc   0.87 $ 317.676  Millions$ 365.815  Millions
Strata Skin Sciences Inc  0.86 $ 32.467  Millions$ 37.551  Millions
Corcept Therapeutics Inc  0.86 $ 685.446  Millions$ 796.455  Millions
Lakeland Industries Inc   0.86 $ 177.648  Millions$ 207.573  Millions
Scientific Industries Inc   0.86 $ 10.636  Millions$ 12.428  Millions
Neuropace Inc   0.85 $ 84.084  Millions$ 98.886  Millions
Eton Pharmaceuticals Inc   0.85 $ 48.265  Millions$ 56.955  Millions
Encompass Health Corporation  0.85 $ 5,512.600  Millions$ 6,505.775  Millions
Incyte Corporation  0.85 $ 4,413.226  Millions$ 5,216.981  Millions
Kiniksa Pharmaceuticals International Plc  0.85 $ 481.166  Millions$ 569.401  Millions
Alphatec Holdings Inc   0.83 $ 641.907  Millions$ 768.916  Millions
Nexgel Inc   0.83 $ 8.670  Millions$ 10.442  Millions
Airsculpt Technologies Inc   0.83 $ 172.101  Millions$ 207.903  Millions
Ispecimen inc   0.82 $ 8.059  Millions$ 9.840  Millions
Amneal Pharmaceuticals Inc   0.82 $ 2,828.747  Millions$ 3,459.399  Millions
Carlisle Companies Incorporated  0.82 $ 5,002.900  Millions$ 6,118.550  Millions
Karyopharm Therapeutics Inc   0.82 $ 142.126  Millions$ 173.896  Millions
Msa Safety Inc  0.81 $ 1,815.309  Millions$ 2,231.792  Millions
Penumbra Inc  0.81 $ 1,240.100  Millions$ 1,535.043  Millions
Cybin Inc   0.80 $ 159.148  Millions$ 198.101  Millions
Gyre Therapeutics Inc   0.80 $ 100.643  Millions$ 125.341  Millions
West Pharmaceutical Services Inc   0.80 $ 2,895.200  Millions$ 3,606.525  Millions
Milestone Scientific Inc   0.80 $ 8.418  Millions$ 10.516  Millions
Exelixis Inc   0.80 $ 2,298.922  Millions$ 2,879.583  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.